Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA

NCT03821987 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03821987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 17, 2018
Completion date
March 30, 2022
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia, engraft failure, stem cell transplant complications